Preface |
|
xi | |
Authors |
|
xiii | |
|
1 Smart Biomaterials in Biomedical Applications |
|
|
1 | (24) |
|
|
1 | (1) |
|
1.2 Scaffold Requirements |
|
|
1 | (2) |
|
1.3 Types of Smart Polymeric Materials |
|
|
3 | (8) |
|
1.3.1 Classification on the Basis of Physical Form |
|
|
3 | (2) |
|
1.3.2 Classification on the Basis of External Stimulus |
|
|
5 | (5) |
|
1.3.3 Advance Functional Nanocarriers |
|
|
10 | (1) |
|
1.4 Biomedical Applications of Smart Polymeric Materials |
|
|
11 | (6) |
|
1.4.1 Dental Applications |
|
|
12 | (1) |
|
1.4.2 Orthopedic Applications |
|
|
12 | (1) |
|
1.4.3 Drug Delivery Applications |
|
|
13 | (1) |
|
1.4.4 Wound Dressing Applications |
|
|
14 | (1) |
|
1.4.5 Tissue Engineering Applications |
|
|
15 | (1) |
|
1.4.6 Ocular Applications |
|
|
16 | (1) |
|
1.4.7 Cardiovascular Applications |
|
|
16 | (1) |
|
1.5 Future Challenges and Prospects |
|
|
17 | (8) |
|
|
17 | (8) |
|
2 Polymers in Dental Applications |
|
|
25 | (18) |
|
|
25 | (1) |
|
2.2 Physical and Mechanical Requirements for Medical Device Materials |
|
|
25 | (2) |
|
2.2.1 Physical Properties |
|
|
26 | (1) |
|
2.2.2 Mechanical Properties |
|
|
26 | (1) |
|
2.2.3 Esthetic Properties |
|
|
26 | (1) |
|
|
26 | (1) |
|
2.2.5 Rheometric Properties |
|
|
27 | (1) |
|
|
27 | (1) |
|
|
27 | (1) |
|
|
27 | (3) |
|
2.3.1 Osseointegrated Implant |
|
|
28 | (1) |
|
2.3.2 Mini-Implants for Orthodontic Anchorage |
|
|
28 | (1) |
|
|
29 | (1) |
|
2.3.4 Transosseous Implant |
|
|
29 | (1) |
|
2.3.5 Endodontic Implants |
|
|
29 | (1) |
|
2.4 Benefits of Dental Implants |
|
|
30 | (1) |
|
2.5 Disadvantages of Dental Implants |
|
|
31 | (1) |
|
|
31 | (6) |
|
2.6.1 Ceramics in Dentistry |
|
|
31 | (1) |
|
|
32 | (1) |
|
2.6.3 Polymeric Materials |
|
|
32 | (1) |
|
2.6.3.1 Polymethyl Methacrylate |
|
|
33 | (1) |
|
2.6.3.2 Poly(Ortho Esters) |
|
|
33 | (1) |
|
2.6.3.3 Dental Restorative Composites |
|
|
34 | (3) |
|
2.6.3.4 Polyethyl Methacrylate (PEMA) and Polybutyl Methacrylate (PBMA) |
|
|
37 | (1) |
|
|
37 | (1) |
|
2.7 Complications in Implant Dentistry |
|
|
37 | (1) |
|
|
38 | (5) |
|
|
38 | (5) |
|
3 Polymers in Orthopedic Devices |
|
|
43 | (22) |
|
|
43 | (1) |
|
3.2 Materials Used in Orthopedic Applications |
|
|
43 | (13) |
|
|
45 | (1) |
|
3.2.1.1 Essential Considerations in Design of Metallic Biomaterials |
|
|
45 | (1) |
|
|
45 | (2) |
|
3.2.1.3 Cobalt-Based Alloys |
|
|
47 | (2) |
|
3.2.1.4 Titanium Alloys Used as Orthopedic Implants |
|
|
49 | (1) |
|
3.2.1.5 Stainless Steels, Cobalt, and Titanium Alloys in Total Joint Replacement |
|
|
49 | (1) |
|
|
50 | (1) |
|
3.2.3 Polymer Composites Materials |
|
|
50 | (1) |
|
3.2.3.1 Fiber-Reinforced Composites (FRC) |
|
|
50 | (1) |
|
3.2.3.2 Filler-Reinforced Composites |
|
|
50 | (1) |
|
|
51 | (3) |
|
|
54 | (1) |
|
3.2.4.2 Polymethyl Methacrylate |
|
|
55 | (1) |
|
3.2.4.3 Poly(ethyleneglycol) |
|
|
55 | (1) |
|
|
56 | (1) |
|
|
56 | (1) |
|
|
56 | (1) |
|
3.4 Material Property Requirements for Bone Replacement |
|
|
57 | (8) |
|
|
58 | (7) |
|
4 Smart Biomaterials in Drug Delivery Applications |
|
|
65 | (36) |
|
|
65 | (1) |
|
4.2 Carrier Materials Used for DDS |
|
|
65 | (1) |
|
4.3 Polymer-Based Nanocarrier Systems |
|
|
66 | (27) |
|
4.3.1 Novel Use of Natural Polymers in Drug Delivery |
|
|
66 | (3) |
|
4.3.2 Amphiphilically Modified Chitosan |
|
|
69 | (3) |
|
4.3.3 Cyclodextrins (CDs) |
|
|
72 | (3) |
|
4.3.4 Aerogel-Based Drug Delivery Systems |
|
|
75 | (1) |
|
4.3.5 Hydrogel-, Microgel-, and Nanogel-Based Drug Delivery Systems |
|
|
75 | (1) |
|
4.3.6 Polymer Micelles-Based Drug Delivery Systems |
|
|
76 | (1) |
|
4.3.7 Dendrimer-Based Drug Delivery Systems |
|
|
77 | (7) |
|
4.3.8 Guar Gum-Based Drug Delivery Systems |
|
|
84 | (1) |
|
4.3.9 Niosomes-Based Drug Delivery Systems |
|
|
84 | (1) |
|
4.3.9.1 Advantages of Niosomes |
|
|
85 | (2) |
|
4.3.10 Liposome-Based Drug Delivery Systems |
|
|
87 | (1) |
|
4.3.11 Carbon-Based Materials (Graphene) in Drug Delivery Systems |
|
|
88 | (4) |
|
4.3.12 Core-Shell Nanoparticles-Based Drug Delivery Systems |
|
|
92 | (1) |
|
4.3.12.1 Core-Shell Nanogels |
|
|
93 | (1) |
|
4.4 Conclusions and Future Prospects |
|
|
93 | (8) |
|
|
93 | (8) |
|
5 Wound-Dressing Implants |
|
|
101 | (24) |
|
|
101 | (1) |
|
|
101 | (1) |
|
|
101 | (1) |
|
|
101 | (1) |
|
|
101 | (1) |
|
5.2.4 Epithelializing Wounds |
|
|
102 | (1) |
|
|
102 | (1) |
|
5.4 Phases of Wound Healing |
|
|
102 | (2) |
|
|
103 | (1) |
|
|
103 | (1) |
|
|
103 | (1) |
|
|
103 | (1) |
|
|
103 | (1) |
|
5.5 Role of Oxygen in Wound Healing |
|
|
104 | (1) |
|
5.6 Requirement for Wound Healing |
|
|
105 | (1) |
|
|
106 | (4) |
|
5.7.1 Reasons for Applying a Dressing |
|
|
106 | (1) |
|
5.7.2 Properties of the "Ideal" Wound Dressing |
|
|
106 | (1) |
|
|
106 | (1) |
|
5.7.3.1 On the Basis of Nature |
|
|
106 | (1) |
|
5.7.3.2 According to Their Ability to Adhere to a Wound |
|
|
107 | (1) |
|
5.7.3.3 According to Their Ability to Permit the Passage of Exudates and Vapor |
|
|
107 | (1) |
|
|
108 | (2) |
|
5.8 Physical Characterization of Wound Dressings |
|
|
110 | (1) |
|
5.9 Natural Polymers in Wound Dressings |
|
|
110 | (3) |
|
|
110 | (1) |
|
|
111 | (1) |
|
|
111 | (1) |
|
5.9.4 Carboxymethylcellulose |
|
|
111 | (1) |
|
|
112 | (1) |
|
5.10 Synthetic Polymers as Wound Dressings |
|
|
113 | (1) |
|
|
113 | (1) |
|
|
113 | (1) |
|
5.10.3 Polyvinyl Pyrrolidone |
|
|
113 | (1) |
|
|
114 | (1) |
|
5.11 Polymer Blends as Wound-Dressing Materials |
|
|
114 | (2) |
|
5.12 Tissue-Engineered Skin Substitutes |
|
|
116 | (9) |
|
|
117 | (8) |
|
6 Smart Biomaterials in Tissue-Engineering Applications |
|
|
125 | (36) |
|
|
125 | (1) |
|
6.2 Foundations of Tissue Engineering |
|
|
125 | (7) |
|
|
125 | (2) |
|
6.2.1.1 Classification and Nomenclature of Stem Cells |
|
|
127 | (1) |
|
|
128 | (2) |
|
6.2.2.1 Prerequisites of Scaffolds |
|
|
130 | (1) |
|
6.2.2.2 Heart Valve Tissue-Engineered Scaffold Requirements |
|
|
130 | (1) |
|
6.2.2.3 Bone Tissue-Engineered Scaffold Requirements |
|
|
131 | (1) |
|
6.2.2.4 Scaffolds Essential Properties |
|
|
131 | (1) |
|
|
132 | (1) |
|
6.2.3.1 Strategies for Biomaterial Presentation of Growth Factors |
|
|
132 | (1) |
|
6.3 Natural Materials in Tissue Engineering |
|
|
132 | (16) |
|
6.3.1 Polymeric and Natural Biomaterial |
|
|
133 | (1) |
|
|
134 | (4) |
|
|
138 | (2) |
|
6.3.1.3 Fibronectin and Fibrin |
|
|
140 | (1) |
|
6.3.1.4 Silk and Spider Silk |
|
|
140 | (2) |
|
6.3.1.5 Self-Assembled Peptides (SAPs)-Based Hydrogels for Tissue Engineering |
|
|
142 | (2) |
|
6.3.1.6 Hyaluronic Acid and Its Derivatives |
|
|
144 | (1) |
|
|
144 | (1) |
|
|
144 | (2) |
|
6.3.1.9 Chitosan and Carboxymethyl Chitosan |
|
|
146 | (2) |
|
6.4 Conclusions and Future Prospects |
|
|
148 | (13) |
|
|
150 | (11) |
|
|
161 | (24) |
|
|
161 | (1) |
|
7.2 Need for Eye Removal: Etiology and Surgery |
|
|
162 | (1) |
|
|
163 | (14) |
|
|
164 | (1) |
|
7.3.1.1 Nonintegrated Implants |
|
|
165 | (1) |
|
7.3.1.2 Quasi-Integrated Implants |
|
|
166 | (1) |
|
|
167 | (2) |
|
7.3.1.4 Porous Quasi-Integrated Implants |
|
|
169 | (1) |
|
7.3.1.5 Complications in Orbital Implants Replacement |
|
|
169 | (1) |
|
|
170 | (2) |
|
|
172 | (1) |
|
7.3.4 Ocular Drug Delivery |
|
|
173 | (4) |
|
7.4 Conclusions and Future Perspectives |
|
|
177 | (8) |
|
|
177 | (8) |
|
8 Polymers in Cardiovascular Implants |
|
|
185 | (22) |
|
|
185 | (1) |
|
8.2 Blood-Biomaterial Interfacial Interaction Mechanism and Biocompatibility of Cardiovascular Biomaterials |
|
|
185 | (2) |
|
8.3 Cardiovascular Biomaterials |
|
|
187 | (2) |
|
8.4 Classification of Cardiovascular Biomaterials |
|
|
189 | (7) |
|
8.4.1 Hydrogel-Based Cardiovascular Biomaterials |
|
|
189 | (1) |
|
8.4.2 Silk-Based Cardiovascular Biomaterials |
|
|
189 | (2) |
|
8.4.3 Polymers Used in Soft-Tissue Engineering |
|
|
191 | (1) |
|
8.4.3.1 Naturally Occurring Polymers |
|
|
191 | (1) |
|
8.4.3.2 Synthetic Polymers |
|
|
191 | (4) |
|
|
195 | (1) |
|
8.5 Surface Modification of Cardiovascular Biomaterials |
|
|
196 | (1) |
|
8.6 Biofunctionalization of Cardiovascular Biomaterials |
|
|
197 | (1) |
|
8.7 Current Challenges for Clinical Trials of Cardiovascular Medical Devices |
|
|
197 | (10) |
|
|
198 | (9) |
|
9 Market Scenario of Biomaterial-Based Devices |
|
|
207 | (12) |
|
|
207 | (1) |
|
9.2 The Biomaterials Market |
|
|
207 | (8) |
|
9.2.1 Orthopedic Biomaterials Worldwide Market |
|
|
207 | (1) |
|
9.2.1.1 Orthopedic Biomaterials Market Growth in the United States |
|
|
208 | (1) |
|
9.2.2 Tissue Engineering and Cell Therapy Global Market Development |
|
|
209 | (1) |
|
9.2.3 The Global Wound Management Market |
|
|
210 | (1) |
|
9.2.3.1 Bioactive Agents in Wound Sealing and Closure |
|
|
211 | (1) |
|
9.2.4 The Global Dental Market |
|
|
211 | (2) |
|
9.2.5 The Cardiovascular Market |
|
|
213 | (1) |
|
9.2.5.1 Asia Driving Diagnostic Cardiology Device Market |
|
|
214 | (1) |
|
9.2.5.2 Key Players in the Cardiovascular Medical Device Industry |
|
|
214 | (1) |
|
9.3 Global Ophthalmology Devices Market |
|
|
215 | (1) |
|
9.4 Global Regenerative Medicines Market |
|
|
216 | (1) |
|
|
216 | (3) |
|
|
217 | (2) |
Index |
|
219 | |